Document is current
Any future updates will be listed below
-
Authors
Moon, Chelsea https://orcid.org/0009-0005-3144-272X
Ghanshani, Raveena https://orcid.org/0000-0003-4861-6034
Crew, Ashley B.
Hughes, Meagan
Hsiao, Jennifer L. https://orcid.org/0000-0002-8843-3630
Lee, Katrina H. https://orcid.org/0000-0003-1871-571X
-
Funding
Funding for this research was provided by:
University of Southern California
- License Information
-
More Information
Article History
Received: 3 August 2025
Accepted: 22 August 2025
First Online: 13 November 2025
Declarations
: ABC has served as an investigator for Incyte and AstraZeneca. JLH is on the Board of Directors for the Hidradenitis Suppurativa Foundation and has served as an advisor, investigator, and/or speaker for AbbVie, Amgen, Aclaris, AstraZeneca, Boehringer Ingelheim, Galderma, Incyte, Navigator Medicines, Novartis, Pfizer, Sanofi, Regeneron, UCB. KHL has served as an advisor and/or investigator for Novartis, Incyte. The rest of the authors have no conflicts to declare.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: ABC has served as an investigator for Incyte and AstraZeneca. JLH is on the Board of Directors for the Hidradenitis Suppurativa Foundation and has served as an advisor, investigator, and/or speaker for AbbVie, Amgen, Aclaris, AstraZeneca, Boehringer Ingelheim, Galderma, Incyte, Navigator Medicines, Novartis, Pfizer, Sanofi, Regeneron, UCB. KHL has served as an advisor and/or investigator for Novartis, Incyte. The rest of the authors have no conflicts to declare.
